2025 Single institution preliminary experience on dose reduction to organs at risk in thoracic radiotherapy for patients enrolled in EORTC-GELA-IIL H10 study protocol on early stage Hodgkin's Lymphoma
Andrea Riccardo Filippi(University of Turin), Umberto Ricardi(Azienda Ospedaliero Universitaria San Giovanni Battista), Angela Botticella(Azienda Ospedaliero Universitaria San Giovanni Battista), L. Todisco, C. Fiandra(University of Turin), Riccardo Ragona, Umberto Vitolo(Candiolo Cancer Institute), A. Namsyl-Kaletka, Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia)
Cited by 4
Related Papers
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
|The Lancet Oncology|2020|1.1k
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
|Radiotherapy and Oncology|2020|646